Bavarian Nordic AS - Company Profile
Powered by 
All the sales intelligence you need on Bavarian Nordic AS in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Bavarian Nordic AS fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Bavarian Nordic AS.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Bavarian Nordic AS Catalyst Calendar
Proactively evaluate Bavarian Nordic AS’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Bavarian Nordic AS Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 31 Dec 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 31 Dec 2019 | Phase II Trial Results | Bavarian Nordic AS; Bristol-Myers Squibb Co; Hoosier Cancer Research Network; Rutgers Cancer Institute of New Jersey; Rutgers The State University of New Jersey | BAVA; BMY | CV-301; nivolumab | Oncology | Anal Cancer; Colon Cancer; Colorectal Cancer; Esophageal Cancer; Gallbladder Cancer; Hepatic - Colorectal Metastasis; Liver Cancer; Metastatic Colorectal Cancer; Pancreatic Cancer; Peritoneal Cancer | Company Press Release |
| 01 Dec 2019 | Phase I Trial Initiation | Bavarian Nordic AS; JPM CBRN Medical; U.S. Department of Defence | BAVA | equine encephalitis vaccine | Infectious Disease | Equine Encephalitis | Clinical Trial Registry |
| 01 Dec 2019 | Phase II Trial Results | Bavarian Nordic AS; F. Hoffmann-La Roche Ltd | BAVA; ROG | atezolizumab; CV-301 | Oncology | Bladder Cancer; Transitional Cell Carcinoma (Urothelial Cell Carcinoma) | Company Press Release |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer